RCUS icon

Arcus Biosciences

179 hedge funds and large institutions have $1.01B invested in Arcus Biosciences in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 70 increasing their positions, 60 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership:

less capital invested

Capital invested by funds: $ → $

11% less funds holding

Funds holding: 200179 (-21)

25% less funds holding in top 10

Funds holding in top 10: 43 (-1)

44% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 43

Holders
179
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$10.2M
Puts
$7.43M
Net Calls
Net Calls Change

Top Buyers

1 +$35.6M
2 +$20.5M
3 +$18.4M
4
BlackRock
BlackRock
New York
+$13.7M
5
Walleye Capital
Walleye Capital
New York
+$7.58M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$185M
2
$100M
3
$80.7M
4
$60.4M
5
$39.6M
6
$32.2M
7
$29.4M
8
$28.5M
9
$26.1M
10
$23.8M
11
$23.4M
12
$21M
13
$18.6M
14
$17.8M
15
$15.9M
16
$14.7M
17
$14.1M
18
$10.5M
19
$10.1M
20
$9.85M
21
$9.68M
22
$8.73M
23
$8.05M
24
$7.79M
25
$7.69M